Science AI Journal
Medicine · Research topic

Open research questions in Systemic Lupus Erythematosus Research

188 unresolved questions extracted from the limitations and future-work sections of 588 Systemic Lupus Erythematosus Research papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Existing systematic reviews on exercise and physical activity for SLE have overlapping and discordant conclusions. There is a need for a comprehensive umbrella review to synthesize evidence on clinical outcomes and map immune-inflammatory outcomes. The methodological quality of included reviews and the certainty of evidence need to be assessed.

    Exercise and physical activity for fatigue, disease activity and immune-inflammatory outcomes in adults with systemic lupus erythematosus: an umbrella review · 2026 · DOI

  • Limited direct comparative evidence on the effectiveness of telitacicept versus belimumab in active SLE. The need for a study to compare the effectiveness and safety of telitacicept and belimumab in patients with active SLE.

    Effectiveness and safety of belimumab and telitacicept in active systemic lupus erythematosus: a retrospective cohort study · 2026 · DOI

  • New technologies that are used to assess the epigenome of immune cells may evolve into useful diagnostic and disease-monitoring tools. Further research is needed to understand the complex role of biomarkers in LN pathogenesis.

    Lupus Nephritis Biomarkers: A Critical Review · 2024 · DOI

  • The complex role of biomarkers in lupus nephritis pathogenesis remains unclear. There is a need for effective biomarkers for monitoring disease activity and predicting treatment outcomes. The development of biomarkers is challenging due to the variability in disease manifestation and response to treatment.

    Lupus Nephritis Biomarkers: A Critical Review · 2024 · DOI

  • The substantial later‐in‐life SLE incidence among men and disease burden in pediatric and older populations should raise awareness in considering SLE in the differential diagnosis in previously underrecognized groups.

    Age‐Specific Incidence of Systemic Lupus Erythematosus in the United States: A Meta‐Analysis of Data From the Centers for Disease Control and Prevention Lupus Registries · 2026 · DOI

  • Background The utility of repeat kidney biopsy in pediatric lupus nephritis (LN) remains debated.

    Repeat kidney biopsy in pediatric lupus nephritis: an analysis of associated clinical-pathological features and outcomes · 2026 · DOI

  • Non-criteria antiphospholipid antibodies (aPLs) were focused in recent years, but the diagnostic and prognostic values of them in OAPS were rarely explored.

    The diagnostic and prognostic values of non-criteria antiphospholipid antibodies in obstetric antiphospholipid syndrome · 2026 · DOI

  • The mechanisms of nuclear hormone receptor variants in immune cell activation and in SLE pathogenesis remain poorly understood.

    Estrogen receptor alpha variants differentially influence proliferation and inflammatory responses in in vitro models of lupus inflammation · 2026 · DOI

  • We focused on cells with innate immune functions since little is known about the role of ERα variants in these cells.

    Estrogen receptor alpha variants differentially influence proliferation and inflammatory responses in in vitro models of lupus inflammation · 2026 · DOI

  • Lysosomal viscosity is an important microenvironmental parameter reflecting the state of lysosomes, but due to the lack of probes to demonstrate the correlation between lysosomal viscosity and RA, the changes in lysosomal viscosity during RA remain unclear.

    Near-Infrared Fluorescent Lysosomal Viscosity Probe with Strong Solid Fluorescence for Rapid Imaging of Rheumatoid Arthritis · 2025 · DOI

  • Epstein-Barr virus (EBV) infection has been epidemiologically associated with SLE, yet its role in pathogenesis remains incompletely defined.

    Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus · 2025 · DOI

  • However, the intricate mechanisms governing tissue infiltration of self-reactive T-cells remain poorly understood.

    SUB1-DOCK2 axis dictates autoimmunity by controlling the migration of self-reactive CD4+ T cells 3038 · 2025 · DOI

  • Symptoms of SLE can vary widely but often include fatigue, pain, photosensitivity, and, in some cases, nephritis.

    Case series: raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sjögren’s syndrome · 2024 · DOI

  • Future research should explore whether dietary changes may be a potential treatment strategy for individuals suffering from severe symptoms and poor quality of life due to SLE and SS.

    Case series: raw, whole, plant-based nutrition protocol rapidly reverses symptoms in three women with systemic lupus erythematosus and Sjögren’s syndrome · 2024 · DOI

  • In addition, SLE can be diagnosed after cancer, although such cases in children have been rarely reported.

    Burkitt's lymphoma in a young boy progressing to systemic lupus erythematosus during follow-up: a case report and literature review · 2024 · DOI

  • Preterm birth (PTB), a major cause of neonatal death or long-term health problems, is a complex condition with a multifactorial etiology, and the underlying mechanism remains unclear.

    Association between antinuclear antibodies status and preterm birth in Japanese pregnant women: a prospective cohort study from Adjunct Study of the Japan Environment and Children’s Study · 2024 · DOI

  • Furthermore, the functional implications of these bacterial communities suggest their involvement in immune modulation, highlighting the potential for further investigation into their roles in SLE pathogenesis and diagnosis.

    Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis · 2024 · DOI

  • However, the relationship between SLE and the urinary microbiome remains underexplored.

    Urinary microbiome profiling as a non-invasive tool for identifying biomarkers in systemic lupus erythematosus and lupus nephritis · 2024 · DOI

  • While hydroxychloroquine is thought to mitigate CV risk factors, its protective role against CV events, particularly arterial ones, remains to be confirmed.

    Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus · 2024 · DOI

  • Immune-mediated mechanisms drive myocardial damage in SLE, making it challenging to detect and characterize cardiac abnormalities. The disease may present with subtle or asymptomatic cardiac involvement, making early detection crucial. The paper highlights the need for a comprehensive approach to cardiovascular involvement in SLE, including multimodal cardiac imaging.

    Multimodal Cardiac Imaging in Systemic Lupus Erythematosus: From Clinical Suspicion to Diagnosis in Clinical Practice · 2026 · DOI

  • There is a need for early detection of silent cardiac injury in SLE patients. Current methods may not be sufficient for detecting and characterizing cardiac abnormalities in SLE. Multimodal cardiac imaging may help address this gap.

    Multimodal Cardiac Imaging in Systemic Lupus Erythematosus: From Clinical Suspicion to Diagnosis in Clinical Practice · 2026 · DOI

  • There is a need for reliable biomarkers for SLE diagnosis and monitoring. The pathogenesis of SLE is complex and not fully understood.

    miR-155-3p in Systemic Lupus Erythematosus: Association with Immune Activation and Renal-Related Parameters · 2026 · DOI

  • Conventional diagnostic and therapeutic approaches often fail to address the complexity of autoimmune disorders. Lack of personalized management of autoimmune disorders.

    ADVANCES IN ARTIFICIAL INTELLIGENCE FOR DIAGNOSIS AND PHARMACOTHERAPEUTIC OPTIMIZATION OF AUTOIMMUNE DISORDERS · 2026 · DOI

  • Data quality and study design are foundational challenges. Large-scale patient datasets raise ethical and governance concerns. Validation is equally important, with molecular signatures needing to be replicated across independent cohorts.

    Applications of artificial intelligence in systemic lupus erythematosus: integrating multi-omics data for precision medicine · 2026 · DOI

  • Traditional analytic approaches have limitations in dealing with the heterogeneity of SLE. There is a need for AI-driven biologically grounded patient stratification.

    Applications of artificial intelligence in systemic lupus erythematosus: integrating multi-omics data for precision medicine · 2026 · DOI

Most-cited papers in Systemic Lupus Erythematosus Research

Most recent work

Find a gap in your own Systemic Lupus Erythematosus Research sub-topic

This page shows what the Systemic Lupus Erythematosus Research literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,044 open questions
Substance Abuse Treatment and Outcomes
1,964 open questions
Smoking Behavior and Cessation
990 open questions
Dementia and Cognitive Impairment Research
974 open questions
Innovations in Medical Education
960 open questions
Physical Activity and Health
923 open questions
Attention Deficit Hyperactivity Disorder
839 open questions
Schizophrenia research and treatment
709 open questions
188 open questions have been extracted from the limitations and future-work passages of 588 Systemic Lupus Erythematosus Research papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.